CCO Hep B Consult – Guidelines
OS :
Version :1.2
Size :17.00Mb
Updated :Feb 19,2020
Developer :Clinical Care Options
Ask AI
You can ask the AI some questions about the app
Q{{(index+1)}}{{item}}Ask AI
Pros and Cons from users' feedback
Based on the users' reviews of the CCO Hep B Consult app, here are three pros and cons: **Pros:** 1. Easy to navigate with a clean interface, allowing users to quickly access guidelines. 2. Valuable resource for professionals in the medical field, offering up-to-date information. 3. Perfect for healthcare providers seeking reliable guidance on hepatitis B treatment. **Cons:** 1. Limited content, failing to provide comprehensive information on various topics. 2. No option to add notes or highlights, making it difficult to personalize knowledge. 3. Lack of search functionality, causing users to spend too much time searching for specific information.
App Downloads
IOS
App Survey
  • How much time do you spend on app applications every day?
      Submission Failed, try again
  • Whether the app response speed affects the experience?
      Submission Failed, try again
  • Does the update frequency of the application affect the experience?
      Submission Failed, try again
  • Does the frequency of application notifications affect the experience?
      Submission Failed, try again
Description
HepB Consult from CCO is an easy-to-use, point-of care resource for all healthcare professionals and others affected by hepatitis B. This Interactive Decision Support Tool draws upon expert consensus guidelines to provide customized recommendations on whether and how to treat hepatitis B in a specific patient setting. Depending on your country, you can choose whether to review advice from US, European, or Asia-Pacific guidelines. The tool asks you a series of questions to define a specific HBV case and then presents personalized recommendations for exactly that individual. HOW TO USE 1. Enter specific patient characteristics through a series of multiple-choice questions 2. Optionally, look up information about each characteristic to better understand why they are necessary to consider when making management choices 3. Instantly see the guideline recommendations for your scenario and consider your practice plan 4. Learn more by reviewing additional online content or entering a new case The goal of the tool is to educate on optimal management choices for monitoring or treating individuals with chronic HBV infection based on current practice guidelines in the United States, Europe, or Asia-Pacific regions. The tool will be helpful for clinicians who provide care for patients with HBV infection, including primary care providers, GI and liver specialists, and those in the fields of hepatology and gastroenterology. The current tool was created in March 2019 and reflects recommendations from the published AASLD, EASL, and APASL guidelines available at that time. Special thanks to Drs. Kosh Agarwal, Paul Y. Kwo, and Grace LH Wong who provided expert advice, knowledge, and support in the development of this Interactive Decision Support Tool. This educational tool is part of a CME-certified program developed independently by CCO - Clinical Care Options, LLC, and produced in collaboration with the American Liver Foundation, the Asian Health Foundation and Practicing Clinicians Exchange. It is supported by an educational grant provided by Gilead Sciences. For additional information on best practices in the management of hepatitis B, including a supplemental educational module and downloadable slideset, go online to clinicaloptions.com/HBVbestpractices. Access to these online educational activities requires login. Registration is fast and free. Register today at clinicaloptions.com. © 2019 CCO - Clinical Care Options, LLC. All rights reserved
{{descriptionMoreText}}
Comments (0)
{{commentText.length}}/{{maxCommentText}}
{{commentError}}{{commentUserError}}
Failed to load data, try again
  • {{comment.commentUser.substring(0, 1)}}
    By {{comment.commentUser}}{{comment.commentDateString}}
    {{comment.comment}}